CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Orgenesis Inc. - ORGS CFD

    0.58
    3.33%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.06
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026151 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026151%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003929 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003929%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Orgenesis Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 0.6
    Open* 0.6
    1-Year Change* -58.9%
    Day's Range* 0.58 - 0.6
    52 wk Range 0.38-2.64
    Average Volume (10 days) 306.40K
    Average Volume (3 months) 1.87M
    Market Cap 19.24M
    P/E Ratio -100.00K
    Shares Outstanding 28.75M
    Revenue 35.63M
    EPS -0.52
    Dividend (Yield %) N/A
    Beta 1.02
    Next Earnings Date Nov 8, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Sep 25, 2023 0.60 -0.01 -1.64% 0.61 0.61 0.60
    Sep 22, 2023 0.61 0.02 3.39% 0.59 0.64 0.57
    Sep 21, 2023 0.59 -0.04 -6.35% 0.63 0.63 0.59
    Sep 20, 2023 0.57 -0.05 -8.06% 0.62 0.62 0.57
    Sep 19, 2023 0.60 -0.04 -6.25% 0.64 0.65 0.59
    Sep 18, 2023 0.68 0.03 4.62% 0.65 0.71 0.65
    Sep 15, 2023 0.65 0.02 3.17% 0.63 0.66 0.63
    Sep 14, 2023 0.68 0.02 3.03% 0.66 0.69 0.66
    Sep 13, 2023 0.69 0.03 4.55% 0.66 0.70 0.66
    Sep 12, 2023 0.67 0.01 1.52% 0.66 0.70 0.66
    Sep 11, 2023 0.67 -0.05 -6.94% 0.72 0.76 0.67
    Sep 8, 2023 0.70 0.06 9.37% 0.64 0.70 0.64
    Sep 7, 2023 0.63 -0.05 -7.35% 0.68 0.68 0.61
    Sep 6, 2023 0.67 -0.06 -8.22% 0.73 0.73 0.66
    Sep 5, 2023 0.69 0.12 21.05% 0.57 0.80 0.57
    Sep 1, 2023 0.56 0.06 12.00% 0.50 0.59 0.50
    Aug 31, 2023 0.49 -0.05 -9.26% 0.54 0.56 0.49
    Aug 30, 2023 0.54 0.03 5.88% 0.51 0.56 0.50
    Aug 29, 2023 0.51 -0.02 -3.77% 0.53 0.54 0.50
    Aug 28, 2023 0.53 0.14 35.90% 0.39 0.55 0.39

    Orgenesis Inc. Events

    Time (UTC) Country Event
    Wednesday, November 8, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    Q3 2023 Orgenesis Inc Earnings Release
    Q3 2023 Orgenesis Inc Earnings Release

    Forecast

    -

    Previous

    -
    Friday, December 15, 2023

    Time (UTC)

    15:00

    Country

    US

    Event

    Orgenesis Inc Annual Shareholders Meeting
    Orgenesis Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 36.025 35.502 7.652 3.899 1.852
    Revenue 36.025 35.502 7.652 3.899 1.852
    Cost of Revenue, Total 1.633 1.221
    Gross Profit 34.392 0.631
    Total Operating Expense 44.679 54.167 103.433 25.874 4.815
    Selling/General/Admin. Expenses, Total 31.926 14.091 15.395 10.19 1.883
    Research & Development 9.169 36.347 87.056 15.453 1.635
    Depreciation / Amortization 0.961 1.864 1.182 1.064 0.203
    Operating Income -8.654 -18.665 -95.781 -21.975 -2.963
    Interest Income (Expense), Net Non-Operating -3.477 -1.789 -1.308 -0.956 -0.035
    Other, Net 0.171 2.503 0.353 0.113 0.008
    Net Income Before Taxes -11.96 -17.951 -96.736 -22.818 -2.99
    Net Income After Taxes -12.169 -18.059 -95.127 -22.589 -2.907
    Net Income Before Extra. Items -14.889 -18.053 -95.088 -22.49 -2.744
    Net Income -14.889 -18.053 1.11 -24.121 -2.744
    Income Available to Common Excl. Extra. Items -14.889 -18.053 -95.088 -22.49 -2.744
    Income Available to Common Incl. Extra. Items -14.889 -18.053 1.11 -24.121 -2.744
    Diluted Net Income -14.889 -18.053 1.11 -24.121 -2.744
    Diluted Weighted Average Shares 25.0963 24.2737 21.3203 15.908 15.423
    Diluted EPS Excluding Extraordinary Items -0.59328 -0.74373 -4.45997 -1.41375 -0.17792
    Diluted Normalized EPS -0.56763 -0.69379 -4.45997 -1.41375 -0.17792
    Unusual Expense (Income) 0.99 1.865
    Other Operating Expenses, Total 0 -0.2 -0.833 -0.127
    Minority Interest -2.72 0.006 0.039 0.099 0.163
    Dividends per Share - Common Stock Primary Issue 0
    Total Extraordinary Items 0 96.198 -1.631
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 6.975 7.044 13.624 7.988 7.201
    Revenue 6.975 7.044 13.624 7.988 7.201
    Total Operating Expense 9.893 10.532 14.303 7.995 11.933
    Selling/General/Admin. Expenses, Total 3.165 3.818 10.539 6.339 7.401
    Research & Development 3.606 3.448 2.064 1.07 3.88
    Depreciation / Amortization 0.361 0.342 0.239 0.24 0.241
    Other Operating Expenses, Total -0.06 -0.081
    Operating Income -2.918 -3.488 -0.679 -0.007 -4.732
    Interest Income (Expense), Net Non-Operating -0.65 -0.645 -0.592 -1.375 -0.756
    Other, Net -0.002 0.001 0.171 -0.001 0.007
    Net Income Before Taxes -3.57 -4.132 -1.1 -1.383 -5.481
    Net Income After Taxes -3.661 -4.261 -1.272 -1.408 -5.492
    Minority Interest -0.466 0.072 -2.825 0.052 0.065
    Net Income Before Extra. Items -4.127 -4.189 -4.097 -1.356 -5.427
    Total Extraordinary Items
    Net Income -4.127 -4.189 -4.097 -1.356 -5.427
    Income Available to Common Excl. Extra. Items -4.127 -4.189 -4.097 -1.356 -5.427
    Income Available to Common Incl. Extra. Items -4.127 -4.189 -4.097 -1.356 -5.427
    Diluted Net Income -4.127 -4.189 -4.097 -1.356 -5.427
    Diluted Weighted Average Shares 28.3578 26.2469 25.5507 25.4039 24.8208
    Diluted EPS Excluding Extraordinary Items -0.14553 -0.1596 -0.16035 -0.05338 -0.21865
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.15495 -0.15259 -0.13465 -0.05389 -0.21865
    Unusual Expense (Income) -0.411 0.283 1.01 -0.02
    Cost of Revenue, Total 3.232 2.722 0.451 0.366 0.411
    Gross Profit 3.743 4.322 13.173 7.622 6.79
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 46.318 25.758 50.077 78.348 28.058
    Cash and Short Term Investments 5.311 5.473 44.923 0.107 14.612
    Cash & Equivalents 5.311 5.473 44.923 0.107 14.612
    Total Receivables, Net 38.871 18.478 3.254 2.035 10.267
    Accounts Receivable - Trade, Net 36.183 15.245 3.085 1.831 3.226
    Total Inventory 0.12 0.118 0.185 0.136 1.66
    Prepaid Expenses 0.958 1.188 1.07 0.382 1.132
    Total Assets 90.928 59.841 77.684 92.495 73.876
    Property/Plant/Equipment, Total - Net 25.138 11.286 4.547 3.03 12.458
    Goodwill, Net 8.187 8.403 8.745 4.812 15.266
    Intangibles, Net 9.694 11.821 13.023 3.348 16.642
    Long Term Investments 0.135 0.152 0.175
    Other Long Term Assets, Total 1.456 1.168 1.117 0.334 0.44
    Total Current Liabilities 15.91 15.365 16.285 42.434 17.161
    Accounts Payable 4.429 5.238 8.649 5.549 4.583
    Accrued Expenses 4.98 2.873 2.74 3.644 4.551
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 4.564 5.903 4.138 0.807 1.249
    Other Current Liabilities, Total 1.937 1.351 0.758 32.434 6.778
    Total Liabilities 63.367 21.353 25.105 87.018 47.771
    Total Long Term Debt 13.438 4.895 7.264 12.143 3.508
    Long Term Debt 13.343 4.854 7.2 12.143 2.847
    Deferred Income Tax 0.058 1.656
    Minority Interest 31.713 0.143 0.149 31.556 24.869
    Other Liabilities, Total 2.306 0.95 1.407 0.827 0.577
    Total Equity 27.561 38.488 52.579 5.477 26.105
    Common Stock 0.003 0.003 0.003 0.002 0.002
    Additional Paid-In Capital 150.355 145.916 140.397 94.691 90.597
    Retained Earnings (Accumulated Deficit) -121.261 -106.372 -88.319 -89.429 -65.163
    Other Equity, Total -0.27 0.207 0.748 0.213 0.669
    Total Liabilities & Shareholders’ Equity 90.928 59.841 77.684 92.495 73.876
    Total Common Shares Outstanding 25.5458 24.3361 24.1678 16.141 15.5403
    Other Current Assets, Total 1.058 0.501 0.645 75.688 0.387
    Note Receivable - Long Term 1.253 2.623 1.012
    Capital Lease Obligations 0.095 0.041 0.064 0.661
    Property/Plant/Equipment, Total - Gross 29.09 14.226 6.736 4.468
    Accumulated Depreciation, Total -3.952 -2.94 -2.189 -1.438
    Treasury Stock - Common -1.266 -1.266 -0.25 0
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 49.45 46.318 31.856 25.458 24.01
    Cash and Short Term Investments 2.674 5.311 3.015 2.303 1.123
    Cash & Equivalents 2.674 5.311 3.015 2.303 1.123
    Total Receivables, Net 40.464 38.871 26.395 21.798 20.846
    Accounts Receivable - Trade, Net 37.739 36.183 23.744 18.786 17.075
    Total Inventory 0.128 0.12 0.095 0.107 0.113
    Prepaid Expenses 5.127 0.958 0.899 0.793 1.438
    Other Current Assets, Total 1.057 1.058 1.452 0.457 0.49
    Total Assets 93.267 90.928 70.69 62.799 58.538
    Property/Plant/Equipment, Total - Net 24.712 25.138 17.566 15.145 11.99
    Goodwill, Net 8.069 8.187 7.764 8.174 8.329
    Intangibles, Net 9.43 9.694 10.72 11.207 11.539
    Long Term Investments 0.136 0.135 1.739 1.75 1.574
    Other Long Term Assets, Total 1.47 1.456 1.045 1.065 1.096
    Total Current Liabilities 13.938 15.91 34.168 16.245 15.253
    Accounts Payable 4.387 4.429 4.538 5.203 6.933
    Accrued Expenses 5.041 4.98 5.627 4.16 3.568
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 2.376 4.564 22.504 5.585 3.375
    Other Current Liabilities, Total 2.134 1.937 1.499 1.297 1.377
    Total Liabilities 65.6 63.367 40.478 31.046 23.836
    Total Long Term Debt 17.369 13.438 5.186 13.972 7.58
    Long Term Debt 17.29 13.343 5.162 13.943 7.544
    Capital Lease Obligations 0.079 0.095 0.024 0.029 0.036
    Minority Interest 31.641 31.713 0.038 0.09 0.155
    Other Liabilities, Total 2.652 2.306 1.086 0.739 0.848
    Total Equity 27.667 27.561 30.212 31.753 34.702
    Common Stock 0.003 0.003 0.003 0.003 0.003
    Additional Paid-In Capital 154.691 150.355 149.465 149.094 146.29
    Retained Earnings (Accumulated Deficit) -125.45 -121.261 -117.164 -115.808 -110.381
    Treasury Stock - Common -1.266 -1.266 -1.266 -1.266 -1.266
    Other Equity, Total -0.311 -0.27 -0.826 -0.27 0.056
    Total Liabilities & Shareholders’ Equity 93.267 90.928 70.69 62.799 58.538
    Total Common Shares Outstanding 27.8615 25.5458 25.5458 24.8208 24.8208
    Note Receivable - Long Term 0 0 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -12.169 -18.059 0.579 -26.041 -2.907
    Cash From Operating Activities -24.924 -26.866 -78.046 -13.22 -1.077
    Cash From Operating Activities 1.978 1.864 1.435 3.806 0.265
    Deferred Taxes -0.103 0 -1.378 0.304 -0.058
    Non-Cash Items 5.246 4.726 -76.784 5.717 0.746
    Changes in Working Capital -19.876 -15.397 -1.898 2.994 0.877
    Cash From Investing Activities -14.133 -12.384 105.61 -13.778 -0.592
    Capital Expenditures -12.416 -7.866 -1.525 -12.129 -0.535
    Other Investing Cash Flow Items, Total -1.717 -4.518 107.135 -1.649 -0.057
    Cash From Financing Activities 39.578 -0.106 5.881 24.098 0.197
    Financing Cash Flow Items 20.593 13.2 0
    Issuance (Retirement) of Stock, Net 2.181 0.91 8.488 0
    Issuance (Retirement) of Debt, Net 16.804 -1.016 -2.607 10.898 0.197
    Foreign Exchange Effects -0.126 -0.238 0.082 -0.058 0.015
    Net Change in Cash 0.395 -39.594 33.527 -2.958 -1.457
    Cash Taxes Paid 0 0.156
    Cash Interest Paid 0.458 0 0.157
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -4.261 -12.169 -10.897 -9.489 -3.997
    Cash From Operating Activities -7.24 -24.924 -14.163 -9.206 -2.792
    Cash From Operating Activities 0.578 1.978 1.463 0.975 0.474
    Deferred Taxes 0.003 -0.103
    Non-Cash Items 0.277 5.246 2.937 2.014 0.963
    Changes in Working Capital -3.837 -19.876 -7.666 -2.706 -0.232
    Cash From Investing Activities -1.307 -14.133 -7.458 -4.863 -1.613
    Capital Expenditures -1.285 -12.416 -6.971 -4.352 -0.902
    Other Investing Cash Flow Items, Total -0.022 -1.717 -0.487 -0.511 -0.711
    Cash From Financing Activities 5.91 39.578 20.095 10.906 0.001
    Financing Cash Flow Items 20.593 1.084 0
    Issuance (Retirement) of Stock, Net 3.441 2.181 2.181 2.181 0.006
    Issuance (Retirement) of Debt, Net 2.469 16.804 16.83 8.725 -0.005
    Foreign Exchange Effects -0.001 -0.126 0.019 -0.051 0.043
    Net Change in Cash -2.638 0.395 -1.507 -3.214 -4.361
    Cash Interest Paid 0.785

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Orgenesis Inc. Company profile

    About Orgenesis Inc

    Orgenesis Inc. is a biotech company operating to unlock the potential of cell and gene therapies (CGTs). The Company is focused on autologous (using the patient’s own cells) therapies with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment. The Company has developed a Point of Care Platform comprised of three components: POCare Therapies, POCare Technologies and POCare Network. Its therapeutic portfolio pipeline is diverse and addresses various clinical needs. POCare Technology uses automated systems across a collaborative POCare Network via a combination of science, technology, engineering and networking.

    Financial summary

    BRIEF: For the nine months ended 30 September 2021, Orgenesis Inc revenues increased from $5.4M to $28.6M. Net loss before extraordinary items decreased 70% to $13M. Revenues reflect POC Services segment increase from $4.3M to $17.1M, Cell process development services segment increase from $1.1M to $11.5M. Lower net loss reflects Other research and development expenses decrease of 43% to $5.6M (expense).

    Equity composition

    Common Stock $.001 Par, 4/13, 1.75B auth., 49,617,903 issd. Insider owns approx.50.56% Effective August 31, 2011 effected a 35 to one forward stock split

    Industry: Medical Equipment, Supplies & Distribution (NEC)

    20271 Goldenrod Lane
    GERMANTOWN
    MARYLAND 20876
    US

    Income Statement

    • Annual
    • Quarterly

    News

    USD/JPY Climbs Towards Key Highs

    USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

    11:32, 26 September 2023

    EUR/USD tests key support

    EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

    14:32, 21 September 2023
    Bank of England building

    BoE leaves rates unchanged, GBP drops further as investors look for more clarity

    The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

    11:45, 21 September 2023
    British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

    GBP softer after CPI surprise, JPY focused on any further hints from Ueda

    GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

    12:42, 20 September 2023

    How to Trade The Break & Retest

    In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

    11:59, 20 September 2023

    Cable coils near lows ahead of Fed and BoE rate decisions

    It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

    14:16, 19 September 2023

    FTSE 100 Technical Outlook - 18 September 2023

    In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

    06:55, 19 September 2023

    People also watch

    XRP/USD

    0.51 Price
    -0.150% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01192

    US100

    14,601.20 Price
    -1.270% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0039%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    Oil - Crude

    89.03 Price
    -0.420% 1D Chg, %
    Long position overnight fee 0.0544%
    Short position overnight fee -0.0763%
    Overnight fee time 21:00 (UTC)
    Spread 0.030

    ETH/USD

    1,587.64 Price
    -0.070% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 5.40

    Still looking for a broker you can trust?

    Join the 555.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading